Stock IMMUNOCELLULAR THERAPEUTICS LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases ImmunoCellular Therapeutics Ltd Nyse

Equities

US4525361055

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for ImmunoCellular Therapeutics Ltd
2023 EOM Pharmaceutical Holdings Announces Topline Results of Its Covid-19 Clinical Trial of Eom613 in Brazil CI
2023 EOM Pharmaceuticals Holdings, Inc. has withdrawn its IPO in the amount of $15 million. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
PR
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
PR
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
PR
ImmunoCellular Therapeutics : Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMUC Stock
  4. Stock
  5. News ImmunoCellular Therapeutics Ltd
  6. Press Releases